Luchetti M, Magni G, Marraro G
Department of Anesthesia and Intensive Care, Fatebenefratelli and Ophthalmiatric Hospital, Milano, Italy.
Reg Anesth Pain Med. 2000 Mar-Apr;25(2):195-200. doi: 10.1053/rapm.2000.0250195.
Ropivacaine 1% has recently been used in clinical trials for peribulbar anesthesia. This study aims to compare the safety and the efficacy of ropivacaine 0.75% with that of a 1:1 mixture of bupivacaine 0.5% and mepivacaine 2% for peribulbar anesthesia.
Two thousand patients undergoing peribulbar anesthesia for elective cataract phacoemulsification were prospectively studied over a 1-year period and randomly assigned to 1 of 2 groups according to the local anesthetic used. One thousand patients were administered peribulbar anesthesia with 9 mL of ropivacaine 0.75% plus 1 mL of hyaluronidase (group R), and 1,000 patients received peribulbar anesthesia with 4 mL of bupivacaine 0.5% plus 4 mL of mepivacaine 2% plus 1 mL of hyaluronidase plus 1 mL of sodium bicarbonate (group BM). Peribulbar anesthesia was always accomplished by the same physician by 2 injections of 5 mL each, with a 25-gauge 25-mm needle. Evaluation was performed by another physician blinded to the technique used and included assessment of pain on local anesthetic injection, ocular and eyelid akinesia, need for top-up injections, onset time and duration of anesthesia, intraoperative analgesia, duration of surgery, hemodynamic parameters, and incidence of perioperative complications.
A greater incidence of pain on injection was found in group BM (P<.001). No difference between the groups was found regarding the onset time and the duration of anesthesia. Perioperative analgesia was satisfactory in both groups with no significant difference. Patients in group R showed a reduced need for top-up injection and a better ocular akinesia at 8 and 10 minutes (P<.01). The akinesia of the eyelid was comparable in the 2 groups and complete in all cases at 8 minutes. Cardiac arrhythmias were more frequent in group BM (P<.01). Local complications did not differ between the groups. An increase in mean artierial blood pressure and heart rate was observed in both groups 1 minute after injection of local anesthetic.
Peribulbar anesthesia with ropivacaine provided better ocular akinesia 8 to 10 minutes after block insertion than a bupivacaine-mepivacaine mixture, which reduced the need for top-up injections. Ropivacaine also caused less pain on injection.
1%罗哌卡因最近已用于球周麻醉的临床试验。本研究旨在比较0.75%罗哌卡因与0.5%布比卡因和2%甲哌卡因1:1混合液用于球周麻醉的安全性和有效性。
对2000例行择期白内障超声乳化术并接受球周麻醉的患者进行为期1年的前瞻性研究,根据所使用的局部麻醉药将其随机分为2组。1000例患者接受9 mL 0.75%罗哌卡因加1 mL透明质酸酶的球周麻醉(R组),1000例患者接受4 mL 0.5%布比卡因加4 mL 2%甲哌卡因加1 mL透明质酸酶加1 mL碳酸氢钠的球周麻醉(BM组)。球周麻醉均由同一位医生通过两次各5 mL的注射完成,使用25号25 mm的针头。由另一位对所用技术不知情的医生进行评估,包括评估局部麻醉药注射时的疼痛、眼球和眼睑运动不能、追加注射的需要、麻醉起效时间和持续时间、术中镇痛、手术时间、血流动力学参数以及围手术期并发症的发生率。
BM组注射时疼痛的发生率更高(P<0.001)。两组在麻醉起效时间和持续时间方面未发现差异。两组围手术期镇痛均令人满意,无显著差异。R组患者在8分钟和10分钟时追加注射的需要减少,眼球运动不能情况更好(P<0.01)。两组眼睑运动不能情况相当,在8分钟时所有病例均完全出现。BM组心律失常更频繁(P<0.01)。两组局部并发症无差异。注射局部麻醉药1分钟后,两组平均动脉血压和心率均升高。
与布比卡因-甲哌卡因混合液相比,罗哌卡因球周麻醉在阻滞插入后8至10分钟时可提供更好的眼球运动不能,减少了追加注射的需要。罗哌卡因注射时引起的疼痛也更少。